LNTH·516544103·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
LNTH (LANTHEUS HLDGS INC) is held by 183 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($620.7M), FARALLON CAPITAL MANAGEMENT LLC ($423.5M), JANUS HENDERSON GROUP PLC ($362.2M). Net institutional sentiment: Mixed.
See how LNTH's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer